Venrock Adviser, LLC Diversified Active

Location: New York, NY

CIK: 0001615982 · Show all filings

Period: Q3 2022 (← Previous) (Next →)

Filing Date: May 15, 2023

Total Value: $648M (100.0% shares, 0.0% debt)

Holdings (31)

— Tricida Inc 14.6%

Value $94.84M Shares 9,050,064 Est. Cost $9.43 Unrealized —

ACRS Aclaris Therapeutics Inc 11.1%

Value $71.84M Shares 4,563,962 Est. Cost $13.57 Unrealized +16.1%

COGT Cogent Biosciences Inc 9.3%

Value $60.25M Shares 4,038,117 Est. Cost $7.95 Unrealized +72.5%

RLMD Relmada Therapeutics Inc 8.7%

Value $56.2M Shares 1,518,056 Est. Cost $31.54 Unrealized -12.2%

VRDN Viridian Therapeutics Inc 6.7%

Value $43.69M Shares 2,130,308 Est. Cost $18.51 Unrealized -2.9%

GHRS GH Research PLC 6.0%

Value $38.73M Shares 3,333,154 Est. Cost $17.70 Unrealized -28.7%

PLRX Pliant Therapeutics Inc 3.5%

Value $22.56M Shares 1,080,000 Est. Cost $19.13 Unrealized 0.0%

MIST Milestone Pharmaceuticals Inc 3.4%

Value $22.29M Shares 2,425,737 Est. Cost $7.58 Unrealized 0.0%

TERN Terns Pharmaceuticals Inc 3.4%

Value $21.84M Shares 3,707,891 Est. Cost $3.72 Unrealized 0.0%

— Marinus Pharmaceuticals Inc 3.2%

Value $20.99M Shares 3,156,803 Est. Cost $11.98 Unrealized —

GOSS Gossamer Bio Inc 3.2%

Value $20.93M Shares 1,747,000 Est. Cost $12.41 Unrealized 0.0%

ANNX Annexon Inc 3.1%

Value $19.9M Shares 3,220,050 Est. Cost $4.00 Unrealized +35.2%

— Instil Bio Inc 3.1%

Value $19.87M Shares 4,105,779 Est. Cost $25.08 Unrealized —

— Akouos Inc 2.9%

Value $18.93M Shares 2,800,566 Est. Cost $4.79 Unrealized —

— Dice Therapeutics Inc 2.4%

Value $15.51M Shares 764,979 Est. Cost $20.28 Unrealized —

— Aerovate Therapeutics Inc 2.1%

Value $13.83M Shares 833,927 Est. Cost $16.40 Unrealized —

LIANY LianBio 1.7%

Value $10.76M Shares 5,378,341 Est. Cost $6.16 Unrealized —

FULC Fulcrum Therapeutics Inc 1.5%

Value $9.708M Shares 1,200,000 Est. Cost $7.16 Unrealized 0.0%

— Inozyme Pharma Inc 1.1%

Value $7.263M Shares 2,709,987 Est. Cost $4.77 Unrealized —

VTYX Ventyx Biosciences Inc 1.1%

Value $7.259M Shares 207,925 Est. Cost $22.14 Unrealized 0.0%

— Prometheus Biosciences Inc 1.1%

Value $7.179M Shares 121,663 Est. Cost $59.01 Unrealized —

SVRA Savara Inc 1.1%

Value $7.06M Shares 4,555,038 Est. Cost $1.30 Unrealized +24.1%

— Provention Bio Inc 0.8%

Value $5.034M Shares 1,118,653 Est. Cost $7.32 Unrealized —

ALT Altimmune Inc 0.7%

Value $4.716M Shares 369,306 Est. Cost $7.36 Unrealized +100.5%

TRVI Trevi Therapeutics Inc 0.7%

Value $4.697M Shares 3,050,022 Est. Cost $2.46 Unrealized +33.5%

— Lyra Therapeutics Inc 0.7%

Value $4.63M Shares 924,170 Est. Cost $5.65 Unrealized —

IMCR Immunocore Holdings PLC 0.7%

Value $4.441M Shares 94,605 Est. Cost $46.94 Unrealized —

ATYR aTyr Pharma Inc 0.6%

Value $4.197M Shares 1,398,889 Est. Cost $5.98 Unrealized -44.0%

— Rallybio Corp 0.6%

Value $3.886M Shares 268,532 Est. Cost $7.55 Unrealized —

— Affimed NV 0.5%

Value $2.943M Shares 1,428,571 Est. Cost $5.52 Unrealized —

CLDX Celldex Therapeutics Inc 0.3%

Value $2.108M Shares 75,000 Est. Cost $15.71 Unrealized +95.2%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	Tricida Inc	9,050,064	$94.84M	14.6%	$9.43	—	COM	89610F101
ACRS	Aclaris Therapeutics Inc	4,563,962	$71.84M	11.1%	$13.57	+16.1%	COM	00461U105
COGT	Cogent Biosciences Inc	4,038,117	$60.25M	9.3%	$7.95	+72.5%	COM	19240Q201
RLMD	Relmada Therapeutics Inc	1,518,056	$56.2M	8.7%	$31.54	-12.2%	COM	75955J402
VRDN	Viridian Therapeutics Inc	2,130,308	$43.69M	6.7%	$18.51	-2.9%	COM	92790C104
GHRS	GH Research PLC	3,333,154	$38.73M	6.0%	$17.70	-28.7%	ORD SH	G3855L106
PLRX	Pliant Therapeutics Inc	1,080,000	$22.56M	3.5%	$19.13	0.0%	COM	729139105
MIST	Milestone Pharmaceuticals Inc	2,425,737	$22.29M	3.4%	$7.58	0.0%	COM	59935V107
TERN	Terns Pharmaceuticals Inc	3,707,891	$21.84M	3.4%	$3.72	0.0%	COM	880881107
—	Marinus Pharmaceuticals Inc	3,156,803	$20.99M	3.2%	$11.98	—	COM	56854Q200
GOSS	Gossamer Bio Inc	1,747,000	$20.93M	3.2%	$12.41	0.0%	COM	38341P102
ANNX	Annexon Inc	3,220,050	$19.9M	3.1%	$4.00	+35.2%	COM	03589W102
—	Instil Bio Inc	4,105,779	$19.87M	3.1%	$25.08	—	COM	45783C101
—	Akouos Inc	2,800,566	$18.93M	2.9%	$4.79	—	COM	00973J101
—	Dice Therapeutics Inc	764,979	$15.51M	2.4%	$20.28	—	COM	23345J104
—	Aerovate Therapeutics Inc	833,927	$13.83M	2.1%	$16.40	—	COM	008064107
LIANY	LianBio	5,378,341	$10.76M	1.7%	$6.16	—	SPONS ADR	53000N108
FULC	Fulcrum Therapeutics Inc	1,200,000	$9.708M	1.5%	$7.16	0.0%	COM	359616109
—	Inozyme Pharma Inc	2,709,987	$7.263M	1.1%	$4.77	—	COM	45790W108
VTYX	Ventyx Biosciences Inc	207,925	$7.259M	1.1%	$22.14	0.0%	COM	92332V107
—	Prometheus Biosciences Inc	121,663	$7.179M	1.1%	$59.01	—	COM	74349U108
SVRA	Savara Inc	4,555,038	$7.06M	1.1%	$1.30	+24.1%	COM	805111101
—	Provention Bio Inc	1,118,653	$5.034M	0.8%	$7.32	—	COM	74374N102
ALT	Altimmune Inc	369,306	$4.716M	0.7%	$7.36	+100.5%	COM	02155H200
TRVI	Trevi Therapeutics Inc	3,050,022	$4.697M	0.7%	$2.46	+33.5%	COM	89532M101
—	Lyra Therapeutics Inc	924,170	$4.63M	0.7%	$5.65	—	COM	55234L105
IMCR	Immunocore Holdings PLC	94,605	$4.441M	0.7%	$46.94	—	ADS	45258D105
ATYR	aTyr Pharma Inc	1,398,889	$4.197M	0.6%	$5.98	-44.0%	COM	002120202
—	Rallybio Corp	268,532	$3.886M	0.6%	$7.55	—	COM	75120L100
—	Affimed NV	1,428,571	$2.943M	0.5%	$5.52	—	COM	N01045108
CLDX	Celldex Therapeutics Inc	75,000	$2.108M	0.3%	$15.71	+95.2%	COM	15117B202